flucytosine has been researched along with lipid a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, C; Nemunaitis, J | 1 |
1 trial(s) available for flucytosine and lipid a
Article | Year |
---|---|
A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-
Topics: Acyltransferases; Antimetabolites; Antimetabolites, Antineoplastic; Combined Modality Therapy; Cytosine Deaminase; Dose-Response Relationship, Drug; Escherichia coli Proteins; Flucytosine; Fluorouracil; Gene Deletion; Gene Transfer Techniques; Humans; Lipid A; Maximum Tolerated Dose; Neoplasms; Nucleoside Deaminases; Salmonella typhimurium; Time Factors | 2001 |